» Articles » PMID: 6479683

Gastrointestinal Symptoms in the Irritable Bowel Compared with Peptic Ulcer and Inflammatory Bowel Disease

Overview
Journal Gut
Specialty Gastroenterology
Date 1984 Oct 1
PMID 6479683
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Symptoms of 50 patients with the irritable bowel syndrome were compared with those of 49 with endoscopically proven peptic ulcer disease and 49 with radiologically or endoscopically proven inflammatory bowel disease using a questionnaire which was administered after the diagnosis was made. Symptoms of bowel dysfunction including pain related to bowel movements were more likely to occur in the irritable bowel syndrome than peptic ulcer disease. Only abdominal distension, straining at stool and scybala, however, were significantly more likely in the irritable bowel syndrome than inflammatory bowel disease. Four symptoms previously shown to be more common in irritable bowel syndrome than in organic abdominal disease were combined. The more of these symptoms that were present, the more likely were the patients to have the irritable bowel syndrome than peptic ulcer disease. Symptoms of gut dysfunction are highly discriminating between irritable bowel syndrome and peptic ulcer disease but less so between irritable bowel syndrome and inflammatory bowel disease.

Citing Articles

A New Criterion for Fluoroquinolone-Associated Disability Diagnosis: Functional Gastrointestinal Disorders.

Cannizzaro D, Naughton L, Freeman M, Martin L, Bennett C, Bove C Medicina (Kaunas). 2021; 57(12).

PMID: 34946316 PMC: 8706438. DOI: 10.3390/medicina57121371.


Second Asian Consensus on Irritable Bowel Syndrome.

Gwee K, Gonlachanvit S, Ghoshal U, Chua A, Miwa H, Wu J J Neurogastroenterol Motil. 2019; 25(3):343-362.

PMID: 31327218 PMC: 6657923. DOI: 10.5056/jnm19041.


Guidelines for the investigation of chronic diarrhoea in adults: British Society of Gastroenterology, 3rd edition.

Arasaradnam R, Brown S, Forbes A, Fox M, Hungin P, Kelman L Gut. 2018; 67(8):1380-1399.

PMID: 29653941 PMC: 6204957. DOI: 10.1136/gutjnl-2017-315909.


AMP-activated protein kinase: a therapeutic target in intestinal diseases.

Sun X, Zhu M Open Biol. 2017; 7(8).

PMID: 28835570 PMC: 5577448. DOI: 10.1098/rsob.170104.


Gastrointestinal symptom severity in irritable bowel syndrome, inflammatory bowel disease and the general population.

Lee A, Spiegel B, Hays R, Melmed G, Bolus R, Khanna D Neurogastroenterol Motil. 2016; 29(5).

PMID: 27981684 PMC: 5393974. DOI: 10.1111/nmo.13003.


References
1.
Manning A, Thompson W, Heaton K, Morris A . Towards positive diagnosis of the irritable bowel. Br Med J. 1978; 2(6138):653-4. PMC: 1607467. DOI: 10.1136/bmj.2.6138.653. View

2.
Thompson W, Heaton K . Functional bowel disorders in apparently healthy people. Gastroenterology. 1980; 79(2):283-8. View

3.
Fielding J . The diagnostic sensitivity of physical signs in the irritable bowel syndrome. Ir Med J. 1981; 74(5):143-4. View

4.
Isgar B, Harman M, Kaye M, Whorwell P . Symptoms of irritable bowel syndrome in ulcerative colitis in remission. Gut. 1983; 24(3):190-2. PMC: 1419934. DOI: 10.1136/gut.24.3.190. View

5.
Harvey R, Salih S, Read A . Organic and functional disorders in 2000 gastroenterology outpatients. Lancet. 1983; 1(8325):632-4. DOI: 10.1016/s0140-6736(83)91802-0. View